Watson Pharmaceuticals (WPI +0.2%) gave back most of the days gains made earlier today following...
Watson Pharmaceuticals (WPI +0.2%) gave back most of the days gains made earlier today following its announcement that it received approval from the FDA on its Abbreviated New Drug Application for Sildenafil Tablets, the generic equivalent to Pfizer's (PFE) Revatio. WPI plans to begin shipping the product as quickly as possible.
From other sites
Video at CNBC.com (Fri, 2:30PM)
Video at CNBC.com (May 11, 2015)
Video at CNBC.com (Apr 9, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs